Omnicom and Saks made M&A ripples, but Elan's $6.7B sale to Perrigo fortifies the case for more deals in the healthcare sector. More
5 Stocks With Ugly Sales Growth — NAVB CTEL HKTV IMMU TRGT
This week, these five stocks have the worst ratings in Sales Growth, one of the eight Fundamental Categories on Portfolio Grader. More
Encore, Encore Capital Group!
Encore Capital uses a more relaxed approach toward collecting debt, but its performance prospects are plenty aggressive. More
3 European Stocks to Buy Now
Investors may be scared to jump into European stocks, but the truth is that they represent great values. Here are three across-the-pond stocks to buy now. More
Samsung Still Dependent on the Smartphone
Despite its diverse set of product lines, Samsung's success is still largely dependent on smartphones like the Galaxy S4. More
Defend Against Fickle Retail With Dividends
Specialty retail isn't exactly known for its boffo dividends, but these three stocks offer respectable protection in the form of regular cash payouts. More
5 Diversified Utilities Stocks to Buy Now
Five Diversified Utilities stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). More
